REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 52 filers reported holding REATA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $423,747 | +13.8% | 4,156 | +1.5% | 0.00% | – |
| Q1 2023 | $372,408 | +135.4% | 4,096 | -1.7% | 0.00% | – |
| Q4 2022 | $158,228 | +53.6% | 4,165 | +1.7% | 0.00% | – |
| Q3 2022 | $103,000 | -16.9% | 4,096 | -0.1% | 0.00% | – |
| Q2 2022 | $124,000 | -6.1% | 4,102 | +1.5% | 0.00% | – |
| Q1 2022 | $132,000 | +22.2% | 4,042 | -1.5% | 0.00% | – |
| Q4 2021 | $108,000 | -89.4% | 4,105 | -59.4% | 0.00% | -100.0% |
| Q3 2021 | $1,017,000 | -29.0% | 10,112 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $1,433,000 | +41.2% | 10,126 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $1,015,000 | -19.6% | 10,194 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $1,262,000 | +27.5% | 10,204 | +0.3% | 0.00% | 0.0% |
| Q3 2020 | $990,000 | -42.8% | 10,171 | -8.3% | 0.00% | -50.0% |
| Q2 2020 | $1,730,000 | +5.6% | 11,088 | -2.3% | 0.00% | 0.0% |
| Q1 2020 | $1,638,000 | -27.5% | 11,346 | +2.7% | 0.00% | 0.0% |
| Q4 2019 | $2,258,000 | +179.5% | 11,046 | +9.8% | 0.00% | +100.0% |
| Q3 2019 | $808,000 | -15.1% | 10,064 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $952,000 | +10.4% | 10,088 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $862,000 | +52.6% | 10,088 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $565,000 | -31.1% | 10,049 | +0.1% | 0.00% | 0.0% |
| Q3 2018 | $820,000 | +133.0% | 10,038 | 0.0% | 0.00% | – |
| Q2 2018 | $352,000 | +70.9% | 10,038 | 0.0% | 0.00% | – |
| Q1 2018 | $206,000 | -27.5% | 10,038 | 0.0% | 0.00% | – |
| Q4 2017 | $284,000 | -9.0% | 10,038 | +0.4% | 0.00% | – |
| Q3 2017 | $312,000 | -1.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $316,000 | +39.8% | 10,000 | 0.0% | 0.00% | – |
| Q1 2017 | $226,000 | +3.7% | 10,000 | 0.0% | 0.00% | – |
| Q4 2016 | $218,000 | -17.4% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $264,000 | +33.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2016 | $198,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |